Medicare Enrolled

Dr. Daniel Marcadis, M.D.

Gastroenterology · Dalton, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
302 POINT NORTH PL, Dalton, GA 30720
7062724127
In practice since 2006 (20 years)
NPI: 1164484663 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Marcadis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marcadis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Marcadis

Dr. Daniel Marcadis is a gastroenterology specialist in Dalton, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Marcadis performed 1,186 Medicare services across 1,092 unique beneficiaries.

Between the years covered by Open Payments, Dr. Marcadis received a total of $4,044 from 39 pharmaceutical and/or device companies across 241 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Marcadis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 19% volume in GA $4,044 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,186
Medicare services
Top 19% in GA for gastroenterology
1,092
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~59 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
241 $197 $734
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
236 $52 $400
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
183 $84 $696
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
111 $37 $80
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
73 $58 $150
Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm
A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length.
45 $77 $411
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
43 $129 $404
Dilation of esophagus 40 $30 $300
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
37 $87 $221
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
34 $8 $15
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
34 $60 $145
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
33 $98 $272
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
24 $75 $217
Esophageal dilation with guide wire and endoscope
A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage.
20 $98 $458
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
20 $121 $328
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
12 $177 $422
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,044
Total received (2018-2024)
Avg $578/year across 7 years
Top 45% in GA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
241
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,044 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$888
2023
$587
2022
$782
2021
$331
2020
$168
2019
$598
2018
$689

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$344
IRONWOOD PHARMACEUTICALS, INC
$71
AIMMUNE THERAPEUTICS, INC.
$70
Janssen Biotech, Inc.
$68
Gilead Sciences, Inc.
$59
Phathom Pharmaceuticals, Inc.
$54
GENZYME CORPORATION
$53
Ipsen Biopharmaceuticals, Inc
$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$45
Intercept Pharmaceuticals, Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$22
Lilly USA, LLC
$21
PFIZER INC.
$13
Top 3 companies account for 54.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$869
AbbVie, Inc.
$318
Janssen Biotech, Inc.
$308
PFIZER INC.
$253
AbbVie Inc.
$239
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$204
Takeda Pharmaceuticals U.S.A., Inc.
$193
Gilead Sciences, Inc.
$181
GENZYME CORPORATION
$157
Celgene Corporation
$128
Cook Medical LLC
$126
Ironwood Pharmaceuticals, Inc
$120
IRONWOOD PHARMACEUTICALS, INC
$99
Phathom Pharmaceuticals, Inc.
$75
Synergy Pharmaceuticals Inc
$70
AIMMUNE THERAPEUTICS, INC.
$70
Regeneron Healthcare Solutions, Inc.
$62
RedHill Biopharma Inc.
$60
Intercept Pharmaceuticals, Inc.
$50
Ipsen Biopharmaceuticals, Inc
$46
Dova Pharmaceuticals
$43
Cook Incorporated
$33
Medtronic, Inc.
$29
Covidien LP
$29
Boston Scientific Corporation
$27
Daiichi Sankyo Inc.
$25
GI Supply, Inc.
$22
AstraZeneca Pharmaceuticals LP
$22
Nestle HealthCare Nutrition Inc.
$21
Alnylam Pharmaceuticals Inc.
$21
Lilly USA, LLC
$21
INTERCEPT PHARMACEUTICALS, INC.
$19
NESTLE HEALTHCARE NUTRITION INC.
$18
Fresenius Kabi USA, LLC
$18
Prometheus Laboratories Inc.
$16
INTRA-SANA LABORATORIES
$14
Osiris Therapeutics Inc.
$13
Olympus America Inc.
$12
Allergan Inc.
$12
Top 3 companies account for 37.0% of all-time payments
Associated products mentioned in payments ›
Amitiza · Barrx · Bravo · COOK MEDICAL FUSION · COOK MEDICAL HEMOSPRAY · CREON · Cook Medical Fusion · Cook Medical Hemospray · Creon · DUPIXENT · Dexilant · Doptelet · ENTYVIO · Entyvio · Epclusa · Fusion Quattro · GATTEX · GI Genius · GIVLAARI · GRAFIX/GRAFIXPL/STRAVIX · HUMIRA · Humira · IDACIO · IMFINZI · INJECTAFER · IQIRVO · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Motegrity · OCALIVA · OMVOH · Olympus EMR & ESD Devices · RELTONE 200 MG · REMICADE · RINVOQ · SKYRIZI · SPECTRA WAVEWRITER · STELARA · TREMFYA · TRULANCE · Talicia · Trintellix · Trulance · VELSIPITY · VIBERZI · VOQUEZNA · WATCHMAN Access System · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in Dalton?
Compare gastroenterologists in the Dalton area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
7
Per 100K population
6.8
County median income
$64,262
Nearest hospital
HAMILTON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Marcadis is a mixed practice specialist, with above-average Medicare volume (top 19% in GA), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Marcadis experienced with colon polyp removal with endoscopic snare?
Based on Medicare claims data, Dr. Marcadis performed 241 colon polyp removal with endoscopic snare services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Marcadis receive payments from pharmaceutical companies?
Yes. Dr. Marcadis received a total of $4,044 from 39 companies across 241 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marcadis's costs compare to other gastroenterologists in Dalton?
Dr. Marcadis's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marcadis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →